in what way was s/he wrong? They can't keep employees, they cannot get any new products through FDA, and they can't keep key distributors. This adds up to declining revenue, after having re-stated revenue multiple times in the past. They make decent products, but have never been able to create true value as a company through any differentiation. Unless there are key dynamics that simply float spine, they are a key target for dissolution in the future, not necessarily acquisition, what would a buyer get?